Phosprint
1 known investors
PhosPrint develops laser bioprinting technology, including an in vivo laser bioprinting platform and GEN1 laser bioprinter used in regenerative medicine and tissue engineering research, such as work toward autologous bioprinted liver tissue. Its systems are used by research institutes and healthcare-focused partners.
Founders & leadership
IZ
Ioanna ZergiotiCEO & President
Investors Β· 1
Frequently asked questions
- What does Phosprint do?
- PhosPrint develops laser bioprinting technology, including an in vivo laser bioprinting platform and GEN1 laser bioprinter used in regenerative medicine and tissue engineering research, such as work toward autologous bioprinted liver tissue. Its systems are used by research institutes and healthcare-focused partners.
- Who are Phosprint's investors?
- Phosprint's investors include Corallia Ventures.